Latest:
Dr. Pili on the Challenges of Translocation RCC
Roberto Pili, MD, discusses clinical challenges in translocation renal cell carcinoma.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Robyn M. Scherber, MD, MPH
Latest:
Dr. Scherber Discusses Ruxolitinib Failure in Myelofibrosis
Robyn M. Scherber, MD, MPH, physician, The Mays Cancer Center, the newly named center of UT Health San Antonio MD Anderson Cancer Center, discusses ruxolitinib (Jakafi) failure in patients with myelofibrosis (MF).
Rodabe N. Amaria
Latest:
Test for Summarization
Kathleen N. Moore, MD, MS, discusses the challenges with utilizing immune-targeted therapy for ovarian cancer, expands on the impact of the tumor microenvironment on the effectiveness of immune checkpoint inhibitors, and details ongoing research with different treatment approaches in ovarian cancer.
Rodabe N. Amaria, MD
Latest:
Dr. Amaria on Genetically Modified TILs in Melanoma
Rodabe N. Amaria, MD, department of Melanoma Oncology, division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses using genetically modified tumor infiltrating lymphocytes (TILs) in patients with advanced melanoma.
Rodney F. Pommier, MD
Latest:
Dr. Pommier Discusses Challenges Associated With the Treatment of Carcinoid Syndrome
Rodney F. Pommier, MD, professor of surgery, director, Neuroendocrine Tumor Program, Oregon Health & Science University, discusses challenges associated with the treatment of carcinoid syndrome.
Rodrigo R. Munhoz, MD
Latest:
Novel Molecular Targets for Drug Development in Non-GIST Sarcomas
The characterization of molecular abnormalities implicated in the tumorigenesis of sarcomas is being increasingly applied to the classification, prognostication and, in particular situations, management of these diseases.
Roeland GW Verhaak, PhD
Latest:
Dr. Verhaak Discusses Genomic Characterization of Diffuse Lower Grade Gliomas
Roeland GW Verhaak, PhD, Assistant Professor, Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, discusses a study that examined the comprehensive and integrative genomic characterization of diffuse lower grade gliomas.
Roger Stupp, MD
Latest:
Dr. Stupp on Final Results for TTFields Added to Chemo in Glioblastoma
Roger Stupp, MD, professor, Neurological Surgery, and associate director, Strategic Initiatives, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, discusses final results of a randomized, multi-center, phase III trial investigating tumor treating fields (TTFields) added to standard chemotherapy in newly diagnosed glioblastoma during the AACR Annual Meeting.